Skip to main content

Xylazine Discussion Forum

Xylazine Discussion Forum

 

 

 

 

 

 

 

 

We are excited to announce that the National Institute on Drug Abuse (NIDA) Center for the Clinical Trials Network (CCTN) is hosting a virtual Xylazine Discussion Forum for CTN investigators.

This meeting is scheduled for Tuesday, September 26, 2023 from 4:00 p.m.– 5:30 p.m. ET.

If you are interested, please register for the meeting here: https://us02web.zoom.us/webinar/register/WN_eF5naRzNTCe6e_GvQe1l3Q.

Speakers:

Jeanmarie Perrone, M.D., Professor of Emergency Medicine, Hospital of the University of Pennsylvania; Director, Division of Medical Toxicology and Addiction Medicine Initiatives, Department of Emergency Medicine, University of Pennsylvania; Founding Director, Penn Medicine Center for Addiction Medicine and Policy

Rachel Haroz, M.D., Associate Professor, Emergency Medicine & Addiction Medicine; Medical Director, Center for Healing, Cooper University Health Care, Cooper Medical School of Rowan University

Paul Wax, M.D., Executive Director, American College of Medical Toxicology, Adjunct Professor, UT Southwestern School of Medicine

Dr. Perrone and Dr. Haroz will highlight the emerging threat of xylazine in the U.S. illicit drug supply, summarize emerging practices for treating people taking xylazine-adulterated opioids, and discuss research gaps and opportunities identified in a recent meeting of experts convened by NIDA. Dr. Wax will describe the ACMT Toxicology Investigators Consortium (ToxIC), a multicenter toxicosurveillance and research network. CTN researchers will be encouraged to participate in discussion and Q&A.

If you are interested, please register for the meeting here: https://us02web.zoom.us/webinar/register/WN_eF5naRzNTCe6e_GvQe1l3Q. Once registered you will receive the Zoom information including an option to download a calendar invitation. If you have any questions about the meeting logistics, please contact CTNSupport@leedmci.com. If you have any questions about this discussion forum, please contact Dr. Kristen Huntley at kristen.huntley@nih.gov.

Individuals with disabilities who need sign language interpreting and/or other reasonable accommodations to participate in this event, should contact Sean Randol at (240) 863-0507 or srandol@leedmci.com or through the Federal Relay (1-800-877-8339). Requests should be made at least five business days in advance of the event.

 

Event Date